Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’ | Annals of the Rheumatic Diseases

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

This article has a Reply. Please see:

Response to: ‘Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’’ by Zou et al - April 01, 2023

Correspondence

Correspondence on ‘A pilot study of tofacitinib for refractory Behçet’s syndrome’

Online download statistics by month:

Online download statistics by month: January 2021 to April 2023

	Abstract	Full	Pdf
Jan 2021	1287	1279	155
Feb 2021	302	297	64
Mar 2021	177	177	31
Apr 2021	47	46	20
May 2021	97	94	20
Jun 2021	137	136	15
Jul 2021	52	52	19
Aug 2021	61	60	12
Sep 2021	180	179	26
Oct 2021	75	73	33
Nov 2021	91	86	28
Dec 2021	127	129	15
Jan 2022	60	58	12
Feb 2022	62	61	11
Mar 2022	42	42	6
Apr 2022	52	55	27
May 2022	48	48	17
Jun 2022	48	47	12
Jul 2022	43	42	10
Aug 2022	119	120	14
Sep 2022	53	51	15
Oct 2022	47	46	17
Nov 2022	47	45	8
Dec 2022	33	33	8
Jan 2023	52	47	8
Feb 2023	35	35	6
Mar 2023	593	27	23
Apr 2023	285	19	27
Total	4252	3384	659